The 2025 edition of the European Society for Medical Oncology(ESMO) was held this week in Berlin, delve into its key ...

From heart disease to neurodegeneration, Novartis makes bold deals in 2025 to expand its drug pipeline globally.

With Eli Lilly's recent acquisition of Verve Therapeutics and its PCSK9 candidate, delve into what the target represents.

Discover five promising Prader-Willi syndrome therapies climbing the clinical ladder and nearing FDA approval in the coming ...

Discover the emerging field of AI-based peptide discovery and design – could this signal the beginning of a golden age for ...

Home to a well-established hub with strong investment and startup activity, discover what makes Cambridge's biotech scene so ...

After being founded in 2017, 3T Biosciences debuted in 2022 with $40 million series A financing. As a company focused on immunotherapy, it is looking to change the future of treatment for solid tumors ...

Named after French neurologist Georges Gilles de la Tourette, who first described the disorder in 1885, Tourette’s syndrome is estimated to affect one in 10 to 1000 people worldwide. A neurological ...

One of the wealthiest countries in the world, Luxembourg is renowned for its gromperekichelcher (potato pancakes), fine wines, and medieval castles. An economic powerhouse in Europe, the country’s ...

The global biotech industry is booming, and by 2025 it will reach an estimated market worth of $729B. But while great innovation is driven by emerging biotechs, these companies often lack resources, ...